Professor Tracy Merlin

Tracy Merlin
Director
School of Public Health
Faculty of Health and Medical Sciences

Professor Tracy Merlin

I am the Managing Director and co-founder of Adelaide Health Technology Assessment (AHTA).

I am a Professor of Health Technology Assessment and the Academic Lead of the Health Economics and Policy Unit in the School of Public Health.

I lead a large and experienced team of researchers undertaking multi-million dollar applied research and evaluation activities on behalf of government and non-government agencies. This research directly informs health policy and clinical practice. The health technology assessment arm of AHTA has been undertaking applied/contract research since 2001.

I am a Director on the Board of the International Network of Agencies for Health Technology Assessment (INAHTA) and co-chaired the INAHTA Quality Assurance Group for two years. I am the current Chair of the English Editorial Board of the international HTA Glossary. I have been a member of Health Technology Assessment International (HTAi) since its inception.

I am a methodologist and clinical epidemiologist. In addition to publishing on my methodological work, I have written well over 150 systematic literature reviews, clinical practice guidelines and health technology assessment reports.

My research and teaching interests include:
> Health technology assessment
> Evidence-based policy
> Systematic reviews
> Meta-analysis
> Pharmaceutical evaluation
> Horizon scanning
> Disinvestment
> Methodological research
> Clinical practice guideline development

Connect With Me

External Profiles

Professor Tracy Merlin

Professor Tracy Merlin

I am the Managing Director and co-founder of Adelaide Health Technology Assessment (AHTA).

I am a Professor of Health Technology Assessment and the Academic Lead of the Health Economics and Policy Unit in the School of Public Health.

I lead a large and experienced team of researchers undertaking multi-million dollar applied research and evaluation activities on behalf of government and non-government agencies. This research directly informs health policy and clinical practice. The health technology assessment arm of AHTA has been undertaking applied/contract research since 2001.

I am a Director on the Board of the International Network of Agencies for Health Technology Assessment (INAHTA) and co-chaired the INAHTA Quality Assurance Group for two years. I am the current Chair of the English Editorial Board of the international HTA Glossary. I have been a member of Health Technology Assessment International (HTAi) since its inception.

I am a methodologist and clinical epidemiologist. In addition to publishing on my methodological work, I have written well over 150 systematic literature reviews, clinical practice guidelines and health technology assessment reports.

My research and teaching interests include:
> Health technology assessment
> Evidence-based policy
> Systematic reviews
> Meta-analysis
> Pharmaceutical evaluation
> Horizon scanning
> Disinvestment
> Methodological research
> Clinical practice guideline development

Adelaide Health Technology Assessment (AHTA)  AHTA Logo

Our Research                                                                           

Adelaide Health Technology Assessment (AHTA) is an applied research group with a national and international reputation in Health Technology Assessment (HTA). AHTA has undertaken over $30 million in applied/contract research since its inception, primarily for the Australian Government Department of Health, to evaluate health services, medicines and other interventions to inform health policy and public funding decisions. This includes assessing the safety, effectiveness and cost-effectiveness of medical services that are being considered for Medicare funding; and the appraisal of pharmaceuticals to determine whether they warrant funding under the Pharmaceutical Benefits Scheme.

In 2016, staff from the former Data Management and Analysis Centre (DMAC) were integrated into AHTA, adding expertise in providing multi-disciplinary support for clients undertaking primary research and data intensive projects in the health field. The newly added teams of statisticians, IT specialists and data managers have a wealth of knowledge with regard to registry and trial data management and analysis, which nicely complements the evidence-based policy and modelling activities undertaken by AHTA.

AHTA's aim is to improve public health and contribute to an efficient and equitable health system by informing health decisions with high quality evidence.

Our mission is:

  • To provide expertise in health technology assessment by
    • Evaluating the safety, effectiveness and value for money of health interventions
    • Predicting the impacts of these health interventions on individuals and society
    • Contributing to best practice, locally, nationally and internationally
  • To provide expertise in the design and conduct of studies, statistical analysis and interpretation, supported by systems that enable high quality data collection and management
  • To provide leadership, education and capacity building in the generation, evaluation and interpretation of evidence.

 

AHTA are proud members of: 

 

HSRAANZ Logo    INAHTA Logo     GIN Logo    HTA Glossary Logo    SSAI Logo

Research and Teaching Interests 

My research interests include: 

  • Developing methodologies for evaluating diagnostic tests to help policy-makers decide whether the tests should be publicly funded
  • Developing methodologies for evaluating co-dependent technologies (eg. the combination of a test and a drug; two tests; a drug and a device). For example, pharmacogenetics / personalised medicines.
  • Exploring the impact of HTA on policy-makers’ decisions
  • Exploring how clinicians interpret evidence-based clinical practice guidelines
  • Exploring the impact of evidence-based clinical practice guidelines on clinical practice
  • Comparing the utility of different methods for grading recommendations in evidence-based clinical practice guidelines
  • Comparing decision thresholds, between health systems, for determining the cost-effectiveness of technologies
  • Mapping the impact of HTA on the Australian health system
  • Mapping and categorising the different types of HTA and developing quality assurance criteria for each type of HTA product.

My teaching interests include: 

  • Health technology assessment
  • Clinical epidemiology
  • Systematic reviews and meta-analysis
  • Horizon scanning for new and emerging technologies
  • Evaluating medical services, devices, programs or pharmaceuticals  to help policy-makers decide whether they should be publicly funded
  • Evaluating medical services or health interventions to inform health professionals and clinicians make the best choice when diagnosing or treating a patient
  • Evaluating currently funded medical services devices, programs or pharmaceuticals to help policy-makers decide whether they should be ‘disinvested’ or stripped of public funding.

Professional Activities

I am an active board member and consultant for local, national and international health technology assessment agencies. 

Date Region Activity Description
2016 International International Scientific Program Committee, 13th Annual Meeting of Health Technology Assessment international (HTAi), Tokyo, 2016
2015-2016 International Chair, INAHTA Congress Tokyo Task Group
2015-2016 International Interim Chair, International HTA Glossary (HTAi and INAHTA joint initiative)
2015-2017 International Director, International Network of Agencies for Health Technology Assessment (INAHTA) Board, Term 2015-2017, Elected.
2015 International Value of Diagnostic Information Platform International Working Group
2015 International Steering Committee, Evidence Synthesis International
2015 International Organising Committee, Global Evidence Summit, Oslo, Norway (Representing the International Network of Agencies for Health Technology Assessment, INAHTA)
2014-2016 Local Member, South Australian Policy Advisory Committee on Technology (SA-PACT), South Australian Department of Health
2014- International Steering Committee, Accelerated Guideline Development Working Group, Guidelines International Network (G-I-N)
2014- International INAHTA representative, HTA Glossary International Steering Committee
2013- International Chair, English Editorial Board, International HTA Glossary (HTAi and INAHTA joint initiative)
2013- International Editorial Board, GMS Health Technology Assessment
2013-2015 International Scientific and Professional Programs Committee Member, Health Technology Assessment international (HTAi), Invited, Term – 2 years
2013 International Abstract reviewer, Health Services Research Association of Australia and New Zealand (HSRAANZ) annual conference, Wellington 2013
2013 International Abstract reviewer and session Chair for Health Technology Assessment international (HTAi) 2013 conference, Seoul, Korea, June 15-16
2012 International Abstract reviewer for International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 5th Asia Pacific conference, Taipei, Taiwan, September 2012
2012-2014 International Co-Chair, International Network of Agencies for Health Technology Assessment (INAHTA) Quality Assurance Group (QAG), Elected
2011-2013 International Scientific and Professional Programs Committee Member, Health Technology Assessment international (HTAi), Invited, Term – 2 years
2011-2013 Local Member, South Australian Health Technology Advisory Group (SA-HTAG), Clinical Senate Standing Committee, South Australian Department of Health
2011 International Abstract reviewer for Health Technology Assessment international (HTAi) 2011 conference, Rio de Janeiro, June 25-26
2011 National Member, Evidence-based Pathology Working Party, Royal College of Pathologists of Australasia
2010 International “Best Conference Poster and Oral presentation” Judge, Health Technology Assessment international (HTAi) 2010 conference, Dublin, June 6-9
2010 International Abstract reviewer for International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 2010 conference, Phuket, Thailand
2010- Local Member, South Australian Medicines Evaluation Panel (SAMEP), Sub-Committee of the South Australian Medicines Advisory Committee, South Australian Department of Health, Panel was awarded “Excellence in Non-Clinical services” by SA Health in 2014
2009-2011 International Scientific and Professional Programs Committee Member. Health Technology Assessment international (HTAi), Invited, Term – 2 years
2009 International “Best Conference Poster” Judge, Health Technology Assessment international (HTAi) 2009 conference, Singapore, June 22-24
2009 International Abstract reviewer for Health Technology Assessment international (HTAi) 2009 conference, Singapore, June 22-24
2009 National Project Executive Committee, Type 2 Diabetes Guidelines – AHTA, Baker IDI, The George Institute
2008 International Abstract reviewer for Health Technology Assessment international (HTAi) 2008 conference, Montreal, July 6-9, 2008
2008 Local Steering Committee, WorkCoverSA clinical practice guidelines for acute/subacute soft tissue injury to the low back
2007-2009 International HTA Council Member, International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
2006-2012 International International Network of Agencies for Health Technology Assessment (INAHTA) Quality Assurance Working Group (QAWG) member
2004-2009 National National Health and Medical Research Council (NHMRC) Guideline Assessment Register Working Party to develop new grading system for evidence-based clinical practice guideline recommendations. Involved revising/redrafting the 1999 NHMRC “levels of evidence” hierarchy – the main evidence-based assessment methodology utilised by Australian health technology assessment organisations, clinical practice guideline developers and evidence-based medicine practitioners.
2005 National National Health and Medical Research Council (NHMRC) Guideline Assessment Register Working Party to develop a discussion workshop on the revised “levels and grades of evidence” for presentation at the 2005 Cochrane Colloquium.
2004 National Working party to standardise minimum requirements and protocols for NHMRC guideline developers.

Appointments

Date Position Institution name
2017 Professor of Health Technology Assessment University of Adelaide
2015 Academic Lead, Health Economics & Policy Academic Unit School of Public Health, University of Adelaide
2013 - 2016 Associate Professor and Senior Research Fellow (Level D) School of Public Health, University of Adelaide
2010 Managing Director Adelaide Health Technology Assessment (AHTA), School of Public Health, University of Adelaide
2010 - 2012 Senior Research Fellow (Level C) Discipline of Public Health, School of Population Health, University of Adelaide
2001 - 2010 Manager (Senior Research Fellow, HEO9 and HEO8) Adelaide Health Technology Assessment (and the National Horizon Scanning Unit), Discipline of Public Health, School of Population Health and Clinical Practice, University of Adelaide
1998 - 2001 Senior Research Officer Australian Safety and Efficacy Register of New Interventional Procedures - Surgical (ASERNIP-S), Royal Australasian College of Surgeons
1990 - 1997 Research Officer Department of Medicine, The Queen Elizabeth Hospital, University of Adelaide

Education

Date Institution name Country Title
2007 - 2015 University of Adelaide Australia PhD (Medicine)
1998 - 2001 University of Adelaide Australia Master of Public Health
1989 - 1989 University of Adelaide Australia Honours, Bachelor of Arts
1986 - 1989 University of Adelaide Australia Bachelor of Arts

Certifications

Date Title Institution name Country
2014 Graduate Certificate Online Learning (Higher Ed) University of Adelaide
2012 Advanced Diploma (Project Management) FPMS International Management Consultants and Accredited Training Providers Australia

Research Interests

Epidemiology, Health Economics, Health Policy, Health Policy & Services, Medical and Health Sciences, Medical Devices, Performance Evaluation, Policy and Administration, Public Health, Public Health and Health Services, Public Policy

Journals

Year Citation
2017 Kessels, S. J. M., Newton, S. S., Morona, J. K. & Merlin, T. L. (2017). Safety and efficacy of wireless pH monitoring in patients suspected of gastro-oesophageal reflux disease: A systematic review. Journal of Clinical Gastroenterology, 51, 9, 777-788. 10.1097/MCG.0000000000000843
2017 Sisnowski, J., Street, J. & Merlin, T. (2017). Improving food environments and tackling obesity: a realist systematic review of the policy success of regulatory interventions targeting population nutrition. PLoS ONE, 12, 8, e0182581-1-e0182581-16. 10.1371/journal.pone.0182581
2016 Lopes, E., Street, J., Carter, D. & Merlin, T. (2016). Involving patients in health technology funding decisions: stakeholder perspectives on processes used in Australia. Health Expectations, 19, 2, 331-344. 10.1111/hex.12356
2016 Merlin, T., Hiller, J. & Ryan, P. (2016). Impact of the "Linked Evidence Approach" Method on Policies to Publicly Fund Diagnostic, Staging, and Screening Medical Tests. MDM Policy & Practice, 1, 1, -. 10.1177/2381468316672465
2015 Varker, T., Forbes, D., Dell, L., Weston, A., Merlin, T., Hodson, S. & O'Donnell, M. (2015). Rapid evidence assessment: increasing the transparency of an emerging methodology. Journal of Evaluation in Clinical Practice, 21, 6, 1199-1204. 10.1111/jep.12405
2014 Merlin, T. L. (2014). The use of the 'linked evidence approach' to guide policy on the reimbursement of personalized medicines. Personalized Medicine, 11, 4, 435-448. 10.2217/pme.14.28
2014 Hodgetts, K., Hiller, J., Street, J., Carter, D., Braunack-Mayer, A., Watt, A. ... Elshaug, A. (2014). Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups. BMC Health Services Research, 14, 1, 1-10. 10.1186/1472-6963-14-204
2014 Marciano, N., Merlin, T., Bessen, T. & Street, J. (2014). To what extent are current guidelines for cutaneous melanoma follow up based on scientific evidence?. International Journal of Clinical Practice, 68, 6, 761-770. 10.1111/ijcp.12393
2014 Merlin, T., Tamblyn, D., Ellery, B. & NAHTA Quality Assurance Group, (2014). What's in a name? developing definitions for common health technology assessment product types of the international network of agencies for health technology assessment (Inahta). International Journal of Technology Assessment in Health Care, 30, 4, 430-437. 10.1017/S0266462314000543
2014 Smithers, L., Lynch, J. & Merlin, T. (2014). Industry self-regulation and TV advertising of foods to Australian children. Journal of Paediatrics and Child Health, 50, 5, 386-392. 10.1111/jpc.12488
2013 Merlin, T., Farah, C., Schubert, C., Mitchell, A., Hiller, J. & Ryan, P. (2013). Assessing personalized medicines in Australia: A national framework for reviewing codependent technologies. Medical Decision Making, 33, 3, 333-342. 10.1177/0272989X12452341
2013 Merlin, T., Lehman, S., Ryan, P. & Hiller, J. (2013). The "linked evidence approach" to assess medical tests: a critical analysis. International Journal of Technology Assessment in Health Care, 29, 3, 343-350. 10.1017/S0266462313000287
2013 Smithers, L., Merlin, T. & Lynch, J. (2013). The impact of industry self-regulation on television marketing of unhealthy food and beverages to Australian children. Medical Journal of Australia, 199, 3, 148-149. 10.5694/mja13.10562
2013 Morona, J., Buckley, E., Jones, S., Reddin, E. & Merlin, T. (2013). Comparison of the clinical effectiveness of different off-loading devices for the treatment of neuropathic foot ulcers in patients with diabetes: a systematic review and meta-analysis. Diabetes-Metabolism Research and Reviews, 29, 3, 183-193. 10.1002/dmrr.2386
2013 Hajiali Afzali, H., Karnon, J. & Merlin, T. (2013). Improving the accuracy and comparability of model-based economic evaluations of health technologies for reimbursement decisions: a methodological framework for the development of reference models. Medical Decision Making, 33, 3, 325-332. 10.1177/0272989X12458160
2012 Tyndall, J., Merlin, T. & Lockwood, C. (2012). Impact of findings from grey literature on the outcomes of systematic reviews on interventions to prevent obesity among children: A systematic review. JBI Database of Systematic Reviews and Implementation Reports, 10, S162-S175.
2011 Mundy, L., Hiller, J. & Merlin, T. (2011). The true role of horizon scanning in Australia: who it informs and why. International Journal of Technology Assessment in Health Care, 27, 1, 95-98. 10.1017/S0266462310001212
2011 Hillier, S., Grimmer, K., Merlin, T., Middleton, P., Salisbury, J., Tooher, R. & Weston, A. (2011). FORM: An Australian method for formulating and grading recommendations in evidence-based clinical guidelines. BMC Medical Research Methodology, 11, 1, 23:1-23:8. 10.1186/1471-2288-11-23
2011 Watt, A., Elshaug, A., Willis, C. & Hiller, J. (2011). Assisted reproductive technologies: A systematic review of safety and effectiveness to inform disinvestment policy. Health Policy, 102, 2-3, 200-213. 10.1016/j.healthpol.2011.07.007
2009 Merlin, T., Weston, A. & Tooher, R. (2009). Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence'. BMC Medical Research Methodology, 9, 34, 1-8. 10.1186/1471-2288-9-34
2009 Kreisz, F., Merlin, T., Moss, J., Atherton, J., Hiller, J. & Gericke, C. (2009). The pre-test risk stratified cost-effectiveness of 64-slice computed tomography coronary angiography in the detection of significant obstructive coronary artery disease in patients otherwise referred to invasive coronary angiography. Heart, Lung & Circulation (Print Edition), 18, 3, 200-207. 10.1016/j.hlc.2008.10.013
2009 Elshaug, A., Moss, J., Littlejohns, P., Karnon, J., Merlin, T. & Hiller, J. (2009). Identifying existing health care services that do not provide value for money. Medical Journal of Australia, 190, 5, 269-273.
2009 Wang, S., Merlin, T., Kreisz, F., Craft, P. & Hiller, J. (2009). Cost and cost-effectiveness of digital mammography compared with film-screen mammography in Australia. Australian and New Zealand Journal of Public Health, 33, 5, 430-436. 10.1111/j.1753-6405.2009.00424.x
2007 Forbes, D., Creamer, M., Phelps, A., Bryant, R., McFarlane, A., Devilly, G. ... Newton, S. (2007). Australian guidelines for the treatment of adults with acute stress disorder and post-traumatic stress disorder. Australian and New Zealand Journal of Psychiatry, 41, 8, 637-648. 10.1080/00048670701449161
2005 Mundy, L., Merlin, T., Parrella, A., Babidge, W., Roberts, D. & Hiller, J. (2005). The Australia and New Zealand horizon scanning network. Australian Health Review, 29, 4, 395-397. 10.1071/ah050395
2005 Mundy, L., Merlin, T., Fitridge, R. & Hiller, J. (2005). Systematic review of endovenous laser treatment for varicose veins. British Journal of Surgery, 92, 10, 1189-1194. 10.1002/bjs.5142
2004 Parsons, J., Merlin, T., Taylor, J., Wilkinson, D. & Hiller, J. (2004). Erratum: Evidence-based practice in rural and remote clinical practice: Where is the evidence? (Australian Journal of Rural Health (2003) vol. 11 (242-248)). Australian Journal of Rural Health, 12, 5, 180-. 10.1111/j.1440-1854.2004.00634.x
2004 Mundy, L., Merlin, T., Maddern, G. & Hiller, J. (2004). Systematic review of safety and effectiveness of an artificial bowel sphincter for faecal incontinence. British Journal of Surgery, 91, 6, 665-672. 10.1002/bjs.4587
2004 Hodgkinson, B., Merlin, T., Moss, J. & Hiller, J. (2004). The effectiveness of intra-articular viscosupplementation for the treatment of osteoarthritis of the knee: a systematic review. Health Care Reports, 2, 5, 109-128.
2003 Parsons, J., Merlin, T., Taylor, J., Wilkinson, D. & Hiller, J. (2003). Evidence-based practice in rural and remote clinical practice: where is the evidence?. Australian Journal of Rural Health, 11, 5, 242-248. 10.1111/j.1440-1584.2003.00527.x
2003 Merlin, T., Hiller, J., Maddern, G., Jamieson, G., Brown, A. & Kolbe, A. (2003). Systematic review of the safety and effectiveness of methods used to establish pneumoperitoneum in laparoscopic surgery. British Journal of Surgery, 90, 6, 668-679. 10.1002/bjs.4203
2001 Merlin, T., Arnold, E., Petros, P., MacTaggart, P., Tulloch, A., Faulkner, K. & Maddern, G. (2001). A systematic review of tension-free urethropexy for stress urinary incontinence: intravaginal slingplasty and the tension-free vaginal tape procedures. BJU International, 88, 9, 871-880. 10.1046/j.1464-4096.2001.01667.x
2000 Merlin, T., Scott, D., Rao, M., Wall, D., Francis, D., Bridgewater, F. & Maddern, G. (2000). The safety and efficacy of laparoscopic live donor nephrectomy: a systematic review. Transplantation, 70, 12, 1659-1666. 10.1097/00007890-200012270-00001
1994 Ratnaike, R. & Chinner, T. (1994). The importance of health education in programs to control diarrhea: Experiences in an Australian aboriginal community. Journal of Health Education, 25, 5, 283-288. 10.1080/10556699.1994.10603046
1993 Jolly, B., Newble, D. & Chinner, T. (1993). Learning Effect of Reusing Stations in an Objective Structured Clinical Examination. Teaching and Learning in Medicine, 5, 2, 66-71. 10.1080/10401339309539593
1992 Ratnaike, R. & Chinner, T. (1992). A Community Health Education System to meet the health needs of Indo-Chinese women. Journal of Community Health, 17, 2, 87-96. 10.1007/BF01321577
1991 Chinner, T. & Dalziel, F. (1991). An exploratory study on the viability and efficacy of a pet-facilitated therapy project within a hospice.. Journal of palliative care, 7, 4, 13-20.

Books

Year Citation
2013 Merlin, T., Newton, S., Ellery, B., Milverton, J. & Farah, C. (2013). Systematic review of the human health effects of wind farms. Australia: National Health & Medical Research Council.
2011 Tamblyn, D., Ellery, B. & Merlin, T. (2011). Review of Interim Funded Service: Brachytherapy for the Treatment of Prostate Cancer: assessment report. Australia: Commonwealth of Australia.
2011 Doidge, J., Merlin, T., Liufu, Z., Tamblyn, D., Jia, L. & Hiller, J. (2011). Review of Interim Funded Service: Vertebroplasty and New Review of Kyphoplasty. Australia: Commonwealth of Australia.
2010 Tamblyn, D., Ellery, B. & Merlin, T. L. (2010). Brachytherapy for the treatment of prostate cancer. Canberra, ACT: Commonwealth of Australia.
2010 Merlin, T. L., Liufu, Z. & Wang, S. (2010). Unattended sleep studies in the diagnosis and reassessment of obstructive sleep apnoea. Canberra, ACT: Commonwealth of Australia.
2006 Merlin, T., Moss, J., Brooks, A., Newton, S., Hedayati, H. & Hiller, J. (2006). B-type natriuretic peptide assays in the daignosis of heart failure: assessment report. MSAC.
2006 Bywood, P., Newton, S., Mundy, L., Merlin, T., Saxon, B. & Hiller, J. (2006). Evidence-based clinical practice guidelines for the use of recombinant and plasma-derived FVIII and FIX products. National Blood Authority.

Conference Papers

Year Citation
2017 Carter, D. A., Merlin, T. & Hunter, D. (2017). Coercing or inducing patients to participate in evidence generation. Australasian Association of Philosophy Conference. Adelaide.
2015 Lopes McInnes, E., Street, J., Carter, D. & Merlin, T. (2015). Stakeholder views on Australian public- and patient-involvement in HTA. HTAi 2015 Annual Meeting - Global efforts in Knowledge Transfer: HTA to Health Policy and Practice. Oslo, Norway.
2013 Lopes do Carmo, E., Street, J. M., Carter, D. A. & Merlin, T. L. (2013). Excluding patient and citizen voices from health-care funding decision-making: what is the public health impact?. Public Health Association of Australia (PHAA) 42nd Annual Conference. Melbourne, Australia.

Conference Items

Year Citation
2017 Vogan, A., Schubert, C. & Merlin, T. (2017). The Impact Of Treatment Timing On The Cost-Effectiveness Of Tests. HTAi. Rome, Italy.
2016 Vogan, A., Schubert, C., Newton, S. & Merlin, T. (2016). What are we missing by limiting the outcome of cost effectiveness analyses of diagnostic tests to cost per correct result?. HTAi. Tokyo, Japan.
2016 Merlin, T. & Moshi, M. R. (2016). Getting a grip on new technologies: AHTA’s journey into m-health and mobile medical applications (MMAs). HTAi. Tokyo, Japan.
2016 Moshi, M. R., Tooher, R. & Merlin, T. (2016). Determining the feasibility of reimbursing mobile health apps in Australia. PHAA 44th Annual Conference and the 20th Chronic Diseases Network Conference. Alice Springs, Northern Territory.
2015 Morona, J. K., Newton, S. & Merlin, T. L. (2015). Meta-analysis of Two Tests via a Common Reference Standard for Detection of Tuberculosis Infections. 12th Annual Conference of Health Technology Assessment International (HTAi). Oslo, Norway..
2015 Vogan, A., Mitchell, A., Tamblyn, D. & Merlin, T. (2015). Managed Entry Schemes: Enabling Access To Oncology Drugs Under Uncertainty. HTAi. Oslo, Norway.
2015 Kessels, S., Morona, J. K., Newton, S. S. & Merlin, T. L. (2015). The impact of an imperfect reference standard. Health Technology Assessment International.
2014 Kessels, S., Schubert, C., Newton, S. S. & Merlin, T. (2014). Assessment of catheter-free (wireless) ambulatory oesophageal pH monitoring for Gastro-esophageal Reflex Disease (GORD). Health Technology Assessment International. Washington, DC.
2014 Vogan, A., Schubert, C., Parsons, J., Morona, J. & Merlin, T. (2014). Assessing the cost-effectiveness of HbA1c testing in the diagnosis of Type II diabetes and the impact of an imperfect diagnostic reference standard. SMDM. Miami, USA.
2014 Vogan, A., Schubert, C., Parsons, J., Morona, J. & Merlin, T. (2014). The impact of an imperfect diagnostic reference standard on the cost-effectiveness of HbA1c testing in the diagnosis of Type II diabetes. HTAi. Washington D.C., USA.
2013 Morona, J. K., Buckley, E. S., Reddin, E. A. & Merlin, T. L. (2013). The use of growth factors to promote healing of diabetic foot ulcers: A Systematic Review.. 2013 Australasian Cochrane Symposium. Melbourne, Australia.
2013 Newton, S., Wang, S., Schubert, C. & Merlin, T. (2013). One small step for an individual, one giant leap for their family: considerations required for assessing the cost effectiveness of genetic tests. Health Technology Assessment International. Seoul, South Korea.
2013 Moshi, M. R., Tamblyn, D. & Merlin, T. (2013). Rise of Co-dependent Technologies: Surveying Stakeholders’ about their opinion on the co-dependent technology framework and decision-making process. SA State Population Health Conference. Adelaide, South Australia.
2013 Morona, J., Newton, S. S., Ellery, B. & Merlin, T. (2013). Genetic testing for VHL disease: limited benefit to the individual, but reduced surveillance for family members. Health Technology Assessment International. Seoul, South Korea.
2013 Newton, S. S. & Merlin, T. (2013). Mutation testing of the RET gene for MEN2. Health Technology Assessment International. Seoul, South Korea.
2013 • Haji Ali Afzali, H., Karnon, J., Merlin, T. & Hajiali Afzali, H. (2013). Improving the accuracy and comparability of model-based economic evaluations of health technologies for reimbursement decisions: a methodological framework for the development of reference models.. 10th Annual Conference of Health Technology Assessment International (HTAi).. Seoul: South Korea.
2009 Newton, S. S., Street, J., Merlin, T. & Hiller, J. (2009). Is MRI effective for staging newly diagnosed rectal carcinoma? That depends on whether it changes management.. The 6th annual Health Technology Assessment International Conference. Singapore.
2006 Newton, S. S., Merlin, T. & Hiller, J. E. (2006). Challenges in updating clinical practice evidence-based guidelines. The 3rd Annual Health Technology Assessment International Conference. Adelaide, Australia.
2006 Newton, S. S., Merlin, T. & Hiller, J. E. (2006). Kyphoplasty for treating vertebral compression fractures with kyphosis. The 3rd Annual Health Technology Assessment International Conference.
2006 Merlin, T., Newton, S. S. & Hiller, J. E. (2006). Brittle bones and painful backs: a systematic review of the safety and effectiveness of vertebroplasty. The 3rd Annual Health Technology Assessment International Conference. Adelaide, Australia.

Report for External Bodies

Year Citation
2017 Mittal, R., Kessels, S., Newton, S., Milverton, J., Parsons, J., Morona, J. ... Merlin, T., (2017). Testing for hereditary mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene - Resubmission, Commenwealth of Australia, Canberra,
2017 Newton, S. S., Salinger, K., Pridham, L., Parsons, J. & Merlin, T., (2017). Assessment of extended half-life clotting factor concentrates,
2016 Morona, J., Vogan, A., Kessels, S., Newton, S., Pridham, L., Ellery, B. ... Merlin, T., (2016). Magnetic resonance imaging of patients with suspected non-ischaemic cardiomyopathies, Canberra,
2016 Kessels, S., Mittal, R., Morona, J., Newton, S., Ellery, B., Milverton, J. ... Merlin, T., (2016). Magnetic resonance imaging of patients with suspected (non-ischaemic) dilated cardiomyopathies, Commonwealth of Australia, Canberra, ACT,
2016 Morona, J., Kessels, S., Vogan, A., Mittal, R., Newton, S., Parsons, J. ... Merlin, T., (2016). Cardiac MRI for myocardial stress perfusion and viability imaging in patients with known or suspected coronary artery disease, Commonwealth of Australia, Canberra, ACT,
2016 Tamblyn, D., Schubert, C. & Merlin, T. L., (2016). Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee, Version 5.0, Commonwealth of Australia,
2015 Newton, S., Ellery, B., Fischer, S., Farah, C., Gum, D., Liufu, Z. ... Merlin, T. L., (2015). Life Saving Drugs Programme Review: Technical Assessment, Australian Government Department of Health, Canberra, ACT,
2015 Kessels, S., Morona, J., Mittal, R., Vogan, A., Newton, S., Schubert, C. & Merlin, T., (2015). Testing for hereditary mutations in the Cystic Fibrosis conductance Transmembrane Regulator (CFTR) gene, Commonwealth of Australia, http://www.msac.gov.au/internet/msac/publishing.nsf/Content/B1083E11E4A3006BCA257BCB0081849E/$File/1216-MSAC-CA-CFTR.pdf,
2014 Parsons, J., Vogan, A., Morona, J. K., Schubert, C. & Merlin, T., (2014). HBA1c test for the diagnosis of diabetes mellitus, Commonwealth of Australia, Canberra, ACT.,
2014 Kessels, S., Schubert, C., Parsons, J., Morona, J. K. & Merlin, T., (2014). Bone mineral density analyses using dual energy x-ray absorptiometry (DXA) for women in their 50th year, Commonwealth of Australia, Canberra, ACT.,
2014 Milverton, J., Ellery, B., Gum, D., Newton, S., Kessels, S., Vogan, A. & Merlin, T., (2014). Milverton J, Ellery B, Gum D, Newton S, Kessels S, Vogan A, Merlin T. Computed tomography colonography for the diagnosis or exclusion of colorectal neoplasia. 2014. MSAC Application 1269. Assessment Report. Commonwealth of Australia, Canberra, ACT.,
2014 Kessels, S., Schubert, C., Newton, S. & Merlin, T., (2014). Catheter-free (wireless) ambulatory oesophageal pH monitoring for gastro-oesophageal reflux disease (GORD), Commonwealth of Australia, Canberra, ACT,
2014 Morona, J. K., Vogan, A., Kessels, S., Gum, D., Milverton, J., Parsons, J. ... Merlin, T., (2014). Nucleic acid amplification testing for active mycobacterial infection, Commonwealth of Australia, Canberra, ACT.,
2014 Ellery, B., Milverton, J., Newton, S., Morona, J. K., Gum, D., Parsons, J. ... Merlin, T., (2014). Retinal photography with a non-mydriatic retinal camera in people with diabetes, Commonwealth of Australia, Canberra, ACT.,
2013 Newton, S., Schubert, C., Morona, J. K., Fitzgerald, P. & Merlin, T., (2013). Genetic testing for hereditary mutations in the RET gene., Commonwealth of Australia, Canberra, ACT.,
2012 Morona, J. K., Newton, S., Wang, S., Tamblyn, D., Ellery, B. & Merlin, T., (2012). Genetic testing for hereditary mutations in the VHL gene that cause von Hippel-Lindau syndrome, Commonwealth of Australia, Canberra, ACT.,
2011 Merlin, T. L., Street, J., Holton, C., Mundy, L., Tamblyn, D., Juneja, V. ... Hennessy, S., (2011). Review of MBS items for specific ophthalmology services under the MBS Quality Framework., Commonwealth of Australia, Canberra, ACT,
2009 Buckley, E. & Merlin, T., (2009). Molecular testing for myeloproliferative disease. Part A - Polycythaemia vera, essential thrombocythaemia and primary myelofibrosis. Part B - Systematic mast cell disease, hypereosinophilic syndromes and chronic eosinophilic leukaemia, Commonwealth of Australia, Canberra, ACT,
2008 Newton, S., Merlin, T., Hedayati, H., Sullivan, T., Street, J. & Hiller, J. E., (2008). MRI for staging of rectal carcinoma, Commonwealth of Australia, Canberra, ACT,

NHMRC Endorsed Guidelines

Year Citation
2016 Merlin, T.; (2016); Clinical Practice Guidelines and Principles of Care for People with Dementia;
2015 Morona, J., Tamblyn, D., Ellery, B. & Merlin, T.; (2015); National Evidence-Based Guideline on Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes;
2011 Merlin, T. & Newton, S.; (2011); Patient blood management guidelines, Module 1 - Critical bleeding/massive transfusion;
2011 Fitridge, R., Templeton, S., Buckley, E., Docter, S., Morona, J., Reddin, E. ... Merlin, T.; (2011); National evidence-based guideline: Prevention, identification and mangement of foot complications in diabetes;
2011 Merlin, T. & Newton, S.; (2011); Clinical practice guidelines: Depression in adolescents and young adults;
2008 Hiller, J. & Merlin, T.; (2008); Guidelines for the management of diabetic retinopathy;
2008 Cox, M., Frank, O., Osti, O., Merlin, T., Atkinson, R. & Jezukaitis, P.; (2008); Clinical guidelines for best practice management of acute and chronic whiplash-associated disorders;
2007 McFarlane, A., Newton, S., Hedayati, H., McCaffrey, N., Erkelens, M., Hazel, S. ... Hiller, J.; (2007); Guidelines for the Treatment of Adults with Acute Stress Disorder and Posttraumatic Stress Disorder;

Theses

Year Citation
2015 Moshi, M. R.; (2015); Delivering a universal neonatal screening programme for sickle cell anaemia in sub- Saharan Africa;
2014 Lopes McInnes, E.; (2014); Public and patient involvement in government health funding decision making in Australia;

Research Funding

National Competitive Schemes

Date Project/No. Investigators Funding Body Amount
2012-2013 Steward or nanny state: Consulting the public about the use of regulations and laws to address childhood obesity Chief - Braunack-Mayer AJ, Street, JM, Reynolds C, Moore V, Warin M, Carter D, Moss J, Merlin T. Australian National Preventive Health Agency Research Grants Program 2011-12 $288,381
2009-2013 Health care in the round: building capacity for integrated decision-making for improving health services. Chief - Jamrozik K, Hiller J, Braunack-Mayer A, Gericke C, Ryan P, Karnon J, Nasir R, Beilby J. Mentors - Moss J, Van der Wilt G, Sculpher M, Rogers W, Merlin T, Furler L. NHMRC Capacity Building Grants in Population Health and Health Services Research $2,352,714

Contract Research - Public Sector Funding

Date Project/No. Investigators Funding Body Amount
2015-2016 Review of Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee AHTA - Merlin T, Tamblyn D, Schubert C ; Consultants - Karnon J, Afzali H, Sculpher M, Drummond M, Roughead L, Sullivan T.; Editors - Biotext (Editorial) – Salisbury J, Irish, J Department of Health (Pharmaceutical Benefits Branch) $539,842
2015-2018 Provision of Health Technology Assessment Services to the Medical Services Advisory Committee (MSAC HTA Panel) AHTA - Merlin T, Newton S, Schubert C, Parsons J, Street J, Carter D, Sullivan T. ; JBI – Aromataris E et al. Department of Health (Medicare Benefits Branch) ~approx $3 million over 3 years
2015-2016 Professional services in relation to the development of emerging technology briefs on behalf of the Health Policy Advisory Committee on Technology (HealthPACT) Merlin T, Parsons J, Ellery B. Queensland Health $147,263
2014-2015 Review of Life Saving Drugs Program Merlin T Postmarket Reviews of PBS Medicines, Pharmaceutical Benefits Branch, Department of Health and Ageing $326,505
2014 Professional services in relation to the development of emerging technology briefs on behalf of the Health Policy Advisory Committee on Technology (HealthPACT) Merlin T, Parsons J, Ellery B. Queensland Health $43,312
2013-2015 Provision of Health Technology Assessment Services to the Medical Services Advisory Committee (MSAC HTA Panel) Merlin T, Newton S, Schubert C, Parsons J, Street J. Department of Health and Ageing (Medicare Benefits Branch) $2,057,250
2012-2013 Systematic literature review of wind farms and human health Merlin T National Health and Medical Research Council $92,134
2012-2016 External evaluation of industry submissions to the Pharmaceutical Benefits Advisory Committee Merlin T, Moss J, Wang S, Schubert C Department of Health and Ageing (Pharmaceutical Benefits Branch) $5,455,151
2012 Systematic review of exposure of children to ‘unhealthy’ food and beverage advertising on television. Merlin T, Smithers L, Lynch J Australian National Preventive Health Agency $51,194
2012 Review of Skin Service items on the MBS Merlin T, Street J, Parsons J Department of Health and Ageing (Medicare Benefits Division) $85,000
2010-2012 Systematic reviews of Ophthalmology specialty items on the MBS Merlin T, Street J, Holton C Department of Health and Ageing (Medicare Benefits Division) $291,369
2008-2012 External evaluation of vaccine and pharmaceutical submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) for funding under the Pharmaceutical Benefits Scheme Merlin T, Moss J, Hiller J Department of Health and Ageing (Pharmaceutical Benefits Branch) $4,045,753
2008-2012 Provision of health technology assessment and research related support services, including independent evaluation of services under consideration by the Medical Services Advisory Committee (MSAC) for Medicare funding. Merlin T, Hiller J, Braunack-Mayer A, Elshaug A, Karnon J, Moss J, Street J Department of Health and Ageing (Medical Benefits Division) $2,500,000
2011 Technologies for the inactivation/ reduction of pathogens in blood products. Merlin T Queensland Health $30,366
2009-2011 Systematic review and update of Type 2 Diabetes Clinical Practice Guidelines Mott K, Merlin T, Shaw J, Neil B, Zimmet P, Zoungas S Department of Health and Ageing (Chronic Disease Division) $1,366,582
2010 Development of a framework and methodology for evaluating co-dependent technologies (personalised medicines). Merlin T Department of Health and Ageing (Medicare Benefits Division and Pharmaceutical Benefits Division) $51,486
2009 Systematic review and development of clinical practice guidelines on the management of acute/subacute soft tissue injury to the lower back Merlin T, Hiller J WorkCover SA $115,000
2009 Development and provision of horizon scanning services for prevention of injury, rehabilitation and compensation Hiller J, Merlin T, Mundy L New Zealand Accident Compensation Corporation $55,677
2007-2009 External evaluation of vaccine submissions to the Pharmaceutical Benefits Advisory Committee Merlin T, Hiller J Department of Health and Ageing (Pharmaceutical Benefits Branch) $394,027
2008 Systematic review and development of clinical practice guidelines on the management of acute/subacute soft tissue injury to the lower back Hiller J, Merlin T South Australian Centre for Trauma and Injury Recovery (TRACsa) $77,069
2007-2008 Develop submission to the Medical Services Advisory Committee for Medicare funding of nurse-led cystoscopy Merlin T, Hiller J Reform and Development Division, Queensland Health $26,488
2006-2010 Provision of Horizon Scanning services on behalf of the Health Policy Advisory Committee on Technology Hiller J, Merlin T, Mundy L, Braunack-Mayer A Department of Health and Ageing (Medicare Benefits Division) $1,166,461
2005-2009 Provision of Assessment and Research Related services on Medical Technologies and Procedures for the Medical Services Advisory Committee Hiller J, Merlin T, Moss J, Braunack-Mayer A, Ryan P Department of Health and Ageing (Medicare Benefits Division) $1,594,372
2004-2008 External evaluation of industry submissions to the Pharmaceutical Benefits Advisory Committee. Moss J, Hiller J, Merlin T, Tonkin A Department of Health and Ageing (Pharmaceutical Benefits Branch) $2,618,082
2005-2008 Provision of Horizon Scanning services on behalf of the Medical Services Advisory Committee and the Australian Health Ministers Advisory Council Hiller J, Merlin T Department of Health and Ageing (Medicare Benefits Division) $237,304
2003-2005 Establish National Horizon Scanning Unit Hiller J, Merlin T Department of Health and Ageing (Medicare Benefits Division) $460,560
2004 NHMRC clinical practice guidelines and national tolerisation protocols for the use of recombinant and plasma derived Factor VIII and Factor IX products for the treatment and management of haemophilia Hiller J, Merlin T National Blood Authority $77,450
2003-2004 Systematic literature review on effective tools for service improvement in the national health priority action areas Hiller J, Merlin T, Bywood P, Cleland L, Ruffin R, Olver I, Tonkin A, Wittert G, Hay National Health Priority Action Council, Department of Health and Ageing $49,500
2002-2004 Systematic literature review on approaches to pain assessment and management Hiller J, Merlin T, Ludbrook G, McIntyre P National Institute of Clinical Studies $60,500
2002-2004 Evidence-based practice in a rural and remote setting Hiller J, Merlin T, Parsons J, Wilkinson, Taylor National Institute of Clinical Studies $18,500

Contract Research and Grants - Australian Industry, donations and international grants

Date Project/No. Investigators Funding Body Amount
2011-2012 Development of NHMRC clinical practice guidelines on the treatment of Acute Stress Disorder and Posttraumatic Stress Disorder in adults and children. Update. Merlin T Australian Centre for Posttraumatic Mental Health $179,852
2008-2009 Systematic review and update of NHMRC clinical practice guidelines for depression in young people Merlin T, Hiller J Beyondblue: the national depression initiative $179,445
2005-2006 Development of NHMRC clinical practice guidelines on the treatment of Acute Stress Disorder and Posttraumatic Stress Disorder Merlin T, Hiller J Australian Centre for Posttraumatic Mental Health $49,167
2004 Systematic literature review on therapeutic arthroscopy for the management of osteoarthritis of the knee. Hiller J, Merlin T , Ryan P, Graves S, Cleland L Medical Benefits Fund (MBF Australia) $57,000
1995-1997 Adult bowel patterns and nutritional status: implications for the elderly. Ratnaike R, Merlin T (nee Chinner) SANDOZ Foundation for Gerontological Research $10,000

Teaching Activities 

I teach undergraduate level topics including Systematic Review, Meta-analysis, Policy Evaluation, Epidemiology, and Public Health Theory and Practice. I also teach a postgraduate online offering and short course in Health Technology Assessment. 

Supervision

I supervise graduate and postgraduate students with research in the areas of Health Technology Assessment, Public Health, Clinical Epidemiology and Health Economics and Policy. 

Memberships

Date Role Membership Country
2013 - ongoing Member Guidelines International Network (G-I-N)
2013 - ongoing Member Society of Medical Decision Making
2010 - ongoing Member Health Services Research Association of Australia and New Zealand
2006 - ongoing Member International Network of Agencies for Health Technology Assessment (INAHTA)
2003 - ongoing Member Cochrane Systematic Reviews of Diagnostic Tests Methods Group
2003 - ongoing Member Health Technology Assessment International (HTAi)
2002 - ongoing Member Cochrane Non-Randomised Studies Methods Group
1991 - 2003 Member Public Health Association of Australia Australia
1991 - 1993 Member Public Health Association of Australia Australia

Editorial Boards

Date Role Editorial Board Name Country
2014 - ongoing Member English Editorial Board of the Health Technology Assessment (HTA) Glossary

Consulting/Advisories

Date Institution Department Organisation Type Country
2014 - ongoing National Health and Medical Research Council Cognitive Decline Partnership Centre, National Dementia Guidelines, Methodological consultant to determine consistency with NHMRC standards and approaches for evidence-based Guideline development. Health services and related Australia
2013 - 2016 National Health and Medical Research Council Health Advice Panel member, services relevant to the development and presentation of evidence based health advice. Health services and related Australia
2013 - ongoing Australian Centre for Posttraumatic Mental Health Posttraumatic Mental Health, Consultant on methods for conducting rapid reviews. Health services and related Australia
2013 - 2014 Australian Government National Drugs and Poisons Scheduling Committee, Office of Health Protection, Department of Health and Ageing, Review of drug submissions to move from one Poisons Schedule to another. Health services and related Australia
2011 - ongoing SA Health Pharmaceutical Services and Strategy Branch Independent review of South Australian Medicines Evaluation Panel (SAMEP) process for evaluation of high cost medicines. Panel was awarded “Excellence in Non-Clinical services” by SA Health in 2014. Health services and related Australia
2010 - 2015 Australian Government National Blood Authority, Methodological consultant to determine consistency with NHMRC standards and approaches for evidence-based Guideline development. Health services and related Australia
2010 - 2013 National Health and Medical Research Council Expert Panel Member, Providers with expertise relevant to the development and presentation of evidence based health advice. Health services and related Australia
2009 - 2012 Australian Government National Drugs and Poisons Scheduling Committee, Office of Health Protection, Department of Health and Ageing, Review of drug submissions to move from one Poisons Schedule to another. Health services and related Australia
2008 - 2010 NHMRC National Blood Authority and the Australian and New Zealand Blood Transfusion Society, Review and development of “Clinical Practice Guidelines on the Use of Blood Components” in collaboration with the National Blood Authority and the Australian and New Zealand Blood Transfusion Society. Health services and related Australia
2006 - 2010 National Health and Medical Research Council NHMRC Guideline Assessment Register, Preferred provider for the provision of evidence-based medicine expertise to organisations developing clinical practice guidelines for National Health and Medical Research Council (NHMRC) approval. Health services and related Australia
2006 - 2010 Australian Government Department of Health and Ageing, Member, Register of Prospective Independent Reviewers. Conduct independent reviews of Pharmaceutical Benefits Advisory Committee (PBAC) recommendations not to list a drug or medicinal preparation on the Pharmaceutical Benefit Scheme (PBS). Health services and related Australia
2006 - 2009 Australian Government Department of Health and Ageing, Panel of Providers of Health Economics Services. Health services and related Australia
2006 - 2008 NHMRC Department of Health and Ageing, Review and development of “NHMRC Best Practice Management (including assessment and treatment) of acute and chronic whiplash associated disorders” in collaboration with South Australian Centre for Trauma and Injury Recovery (TRACsa). Health services and related Australia
2005 - ongoing National Health and Medical Research Council National Stroke Foundation, Consultancy to NHMRC to critically appraise evidence base in “Clinical Guidelines for Stroke Rehabilitation and Recovery”. Health services and related Australia
2004 - 2006 Department of Human Services Clinical Innovation Agency, Victoria, Preferred provider of systematic literature reviews. Health services and related Australia
2003 - 2004 National Health and Medical Research Council Review and development of “NHMRC Clinical Practice Guidelines on the Management of Diabetic Retinopathy” in collaboration with Australian Diabetes Society Health services and related Australia
2002 - 2005 National Health and Medical Research Council NHMRC Guideline Assessment Register, Preferred provider for the provision of evidence-based medicine expertise to organisations developing clinical practice guidelines for National Health and Medical Research Council (NHMRC) approval. Health services and related Australia
2001 - 2002 National Health and Medical Research Council Review of draft Clinical Practice Guidelines for Management of Early Prostate Cancer. Health services and related Australia
Position
Director
Phone
83133575
Campus
North Terrace
Building
Adelaide Health and Medical Sciences Building
Room Number
WS9085.01
Org Unit
Adelaide Health Technology Assessment

top